Company Filing History:
Years Active: 2020
Title: Sameer Sharma: Innovator in Tumor Treatment
Introduction
Sameer Sharma is a notable inventor based in Kangra, India. He has made significant contributions to the field of medical science, particularly in the treatment of tumors associated with neurofibromatosis type-2. His innovative approach has the potential to improve the lives of many patients suffering from this condition.
Latest Patents
Sameer Sharma holds a patent for the invention titled "Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2." This invention discloses a method for treating, preventing, or ameliorating tumors or symptoms resulting from a defective neurofibromatosis type-2 gene. The method involves administering a therapeutically effective amount of a ubiquitin-proteasome system inhibitor, which inhibits or slows the growth of neurofibromatosis type-2-deficient tumors or associated symptoms. Additionally, the invention includes methods for diagnosing and screening patients for neurofibromatosis type-2 and mesothelioma. He has 1 patent to his name.
Career Highlights
Sameer Sharma is currently associated with Bioxcel Corporation, where he continues to work on innovative solutions in the medical field. His research and development efforts are focused on advancing treatments that can significantly impact patient care.
Collaborations
Some of his notable coworkers include Krishnan Nandabalan and Luca Rastelli, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Sameer Sharma's work in the field of tumor treatment showcases his dedication to improving healthcare outcomes. His innovative patent reflects a promising advancement in the treatment of neurofibromatosis type-2, highlighting the importance of continued research and development in this area.